Annmarie L. Sabb

WAY-163909 [(7 bR,10 aR)-1,2,3,4,8,9,10,10 a-Octahydro-7 bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole]: A Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Preclinical Antipsychotic-Like Activity

Karen L. Marquis, Annmarie L. Sabb, Sheree F. Logue et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 145 citations

Medicine, Medicinal Chemistry, Pharmacology +17

Antidepressant-like effects of the novel, selective, 5-HT2C receptor agonist WAY-163909 in rodents

Sharon Rosenzweig‐Lipson, Annmarie L. Sabb, Gary Stack et al. · Psychopharmacology · 2007 · 100 citations

Medicine, Neuroscience, Pharmacology +13

WAY-163909 [(7 bR, 10 aR)-1,2,3,4,8,9,10,10 a-Octahydro-7 bH-cyclopenta-[b][1,4]diazepino[6,7,1hi]indole], a Novel 5-Hydroxytryptamine 2C Receptor-Selective Agonist with Anorectic Activity

John Dunlop, Annmarie L. Sabb, Hossein Mazandarani et al. · Journal of Pharmacology and Experimental Therapeutics · 2005 · 100 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Antiobesity-like effects of the 5-HT2C receptor agonist WAY-161503

Sharon Rosenzweig‐Lipson, Jean Zhang, Hossein Mazandarani et al. · Brain Research · 2006 · 78 citations

Medicine, Endocrinology, Pharmacology +13

The Preclinical Pharmacological Profile of WAY-132983, a Potent M1 Preferring Agonist

Adam C. Bartolomeo, Jerry J. Buccafusco, Nancy J. Kille et al. · Journal of Pharmacology and Experimental Therapeutics · 2000 · 55 citations

Medicine, Neuroscience, Pharmacology +17